Influences of intravesical BCG therapy in lower urinary tract symptom
Not Applicable
Recruiting
- Conditions
- rothelial carcinoma in situ of the bladder
- Registration Number
- JPRN-UMIN000040796
- Lead Sponsor
- Kinki Central Hospital of Mutual Aid Association of Public School Teachers
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects deemed inappropriate to participate in this study by the principle investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Influences of intravesical BCG therapy on local symptoms Before and during intravesical injection of BCG 2 weeks, 3 months, 6 months after intravesical BCG therapy
- Secondary Outcome Measures
Name Time Method Influences of on systemic symptoms Discontinuation rate of intravesical BCG therapy and its reason Recurrence after intravesical BCG therapy